An evaluation of the proposed DSM-5 cannabis use disorder criteria using Australian national survey data.
- Authors
- Mewton, Louise; Slade, Tim; Teesson, Maree
- Year
- 2013
- Journal
- Journal of studies on alcohol and drugs
- PMID
- 23739026
- DOI
- 10.15288/jsad.2013.74.614
OBJECTIVE: The aim of the current study was to evaluate the proposed cannabis use disorder criteria for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) using epidemiological data. METHOD: Data came from the 2007 Australian National Survey of Mental Health and Wellbeing. Lifetime DSM-IV and DSM-5 cannabis use disorder diagnoses were assessed using a modified version of the World Mental Health Composite International Diagnostic Interview among those respondents who had used cannabis more than five times (n = 1,639; 37% female). RESULTS: The prevalence of cannabis use disorder decreased from DSM-IV (6.2%) to DSM-5 (5.4%). Two fifths of those with DSM-IV cannabis abuse would fall below the threshold for DSM-5 cannabis use disorder. More than a third of those classified as DSM-IV "diagnostic orphans" would meet criteria for a DSM-5 mild, moderate, or severe cannabis use disorder. In terms of demographic and clinical characteristics, those who converted from no disorder in DSM-IV to a disorder under DSM-5 were similar to those diagnosed with a disorder according to both systems. Those who converted to no disorder under DSM-5 tended to be young men with cross-substance involvement and high levels of cannabis consumption. CONCLUSIONS: Although a previous study of the Australian population found that alcohol use disorders increase considerably under DSM-5, the current study found a reduction in cannabis use disorders in the transition from DSM-IV to DSM-5. This is likely the result of the high ratio of cannabis abuse to dependence when compared with other substances. Given the implications the proposed changes have on the epidemiology of substance use disorders, further research is needed to determine whether the proposed criteria are optimal.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | 2014 | 24315570 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Prevalence of Cannabis Use Disorder: A Meta-Analysis of Population Surveys. | Boness CL et al. | — | 2025 | → |
| Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use. | Fink DS et al. | — | 2022 | → |
| Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents. | Nielsen S et al. | — | 2020 | → |
| An Examination of Comorbid Psychiatric Disorders in Disordered Gamblers Versus Other Substance-Related Disorders. | Nicholson R et al. | — | 2019 | → |
| Key Considerations in Planning for Substance Use Treatment: Estimating Treatment Need and Demand. | Ritter A et al. | — | 2019 | → |
| Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. | Campbell G et al. | — | 2019 | → |
| Falling rates of marijuana dependence among heavy users. | Davenport S | — | 2018 | → |
| Nineteen and Up study (19Up): understanding pathways to mental health disorders in young Australian twins. | Couvy-Duchesne B et al. | — | 2018 | → |
| Perceived barriers for cannabis cessation: Relations to cannabis use problems, withdrawal symptoms, and self-efficacy for quitting. | Zvolensky MJ et al. | — | 2018 | → |
| Social cognitive predictors of treatment outcome in cannabis dependence. | Gullo MJ et al. | — | 2017 | → |
| Substantiated childhood maltreatment and young adulthood cannabis use disorders: A pre-birth cohort study. | Abajobir AA et al. | — | 2017 | → |
| Concordance of ICD-11 and DSM-5 definitions of alcohol and cannabis use disorders: a population survey. | Lago L et al. | — | 2016 | → |
| Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form. | Bonn-Miller MO et al. | — | 2016 | → |
| Psychosocial interventions for cannabis use disorder. | Gates PJ et al. | — | 2016 | → |
| From DSM-IV to DSM-5 alcohol use disorder: an overview of epidemiological data. | Bartoli F et al. | — | 2015 | → |
| Inter-observer reliability of DSM-5 substance use disorders. | Denis CM et al. | — | 2015 | → |
| Natural outcome of cannabis use disorder: a 3-year longitudinal follow-up. | Feingold D et al. | — | 2015 | → |
| Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Goldstein RB et al. | — | 2015 | → |
| Alcohol consumption and symptoms as predictors for relapse of DSM-5 alcohol use disorder. | Tuithof M et al. | — | 2014 | → |
| Comparing factor, class, and mixture models of cannabis initiation and DSM cannabis use disorder criteria, including craving, in the Brisbane longitudinal twin study. | Kubarych TS et al. | — | 2014 | → |
| Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients. | Kelly SM et al. | — | 2014 | → |
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | Agrawal A et al. | — | 2014 | → |
| The relationship between cannabis outcome expectancies and cannabis refusal self-efficacy in a treatment population. | Connor JP et al. | — | 2014 | → |
| Predicting persistency of DSM-5 alcohol use disorder and examining drinking patterns of recently remitted individuals: a prospective general population study. | Tuithof M et al. | — | 2013 | → |